Holler, A., Zech, M., Ghorashian, S., Pike, R., Hotblack, A., Veliça, P., Xue, S.-A., Chakraverty, R., Morris, E. C. and Stauss, H. J. (2016) “Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy”, Haematologica. Pavia, Italy, 101(4), pp. 482-490. doi: 10.3324/haematol.2015.132712.